Studying TAK-243 in Patients With Advanced Cancer

NCT06223542 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

95

Enrollment

NIH

Sponsor class

Conditions

Advanced Lymphoma
Advanced Malignant Solid Neoplasm
Indolent Non-Hodgkin Lymphoma
Metastatic Malignant Solid Neoplasm
Recurrent Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography Test
PROCEDURE: Magnetic Resonance Imaging
DRUG: UAE Inhibitor TAK-243

Sponsor

National Cancer Institute (NCI)